Phillip Andrew Futreal

Title: The Innovations of Phillip Andrew Futreal

Introduction

Phillip Andrew Futreal is a notable inventor based in Durham, NC (US). He is recognized for his contributions to the field of genetics, particularly in relation to cancer research. His work has significant implications for the diagnosis and treatment of cancer, especially breast and ovarian cancer.

Latest Patents

Futreal holds 1 patent related to materials and methods for identifying and sequencing the BRCA2 gene. This patent discloses the identification and sequencing of the BRCA2 gene, along with the amino acid sequence of the corresponding BRCA2 polypeptides. The patent also addresses BRCA2 alleles, including those with mutations that predispose individuals to develop cancer. Furthermore, it discusses the uses of BRCA2 nucleic acid and polypeptides in diagnostic, prognostic, or therapeutic treatments for cancer.

Career Highlights

Throughout his career, Futreal has worked with prestigious institutions, including Duke University and Cancer Research Campaign Technology Limited. His research has contributed to a deeper understanding of genetic factors associated with cancer, paving the way for advancements in medical science.

Collaborations

Futreal has collaborated with notable scientists such as Richard Francis Wooster and Alan Ashworth. These collaborations have enhanced the impact of his research and have contributed to significant advancements in the field of cancer genetics.

Conclusion

Phillip Andrew Futreal's innovative work in the identification and sequencing of the BRCA2 gene has made a lasting impact on cancer research. His contributions continue to influence the development of diagnostic and therapeutic strategies for cancer treatment.